A Phase 2 clinical trial of CTP-499 in Necrobiosis lipoidica
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2018
At a glance
- Drugs PCS 499 (Primary)
- Indications Necrobiosis lipoidica
- Focus Adverse reactions
- Sponsors Processa Pharmaceuticals
- 01 Jun 2018 According to a Processa Pharmaceuticals media release, this trial will begin in the fourth quarter of 2018.
- 28 Mar 2018 New trial record
- 21 Mar 2018 According to a Processa Pharmaceuticals media release, the Company plans to start this trial in 2018.